COTTONWOOD HEIGHTS, UT / ACCESSWIRE / May 8, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that its financial results for its third quarter of fiscal year 2019 ended March 31, 2019 will be released before the market opens on Tuesday, May 14, 2019.
The company also will hold a conference call at 8:30 AM EST on Tuesday, May 14, 2019 to discuss the results with analysts and institutional investors. The call will include remarks by the company’s management team as well as questions and answers. Interested persons may access the live call by dialing (844) 602-0380 (U.S. and Canadian callers) or (862) 298-0970 (international callers). It is recommended that participants call or log on 10 minutes ahead of the scheduled start time to ensure proper connection. A replay will be available 1 hour after the live call until Midnight on June 30, by dialing (877) 481-4010, Pin 47756.
About Dynatronics Corporation
Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Dynatron Solaris®, Hausmann™, Physician’s Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.
Contact:
Dynatronics Corporation
Investor Relations
Jim Ogilvie
(801) 727-1755
jim.ogilvie@dynatronics.com
For additional information, please visit: www.dynatronics.com
Like Dynatronics on Facebook
Connect with Dynatronics on LinkedIn
Follow us on Twitter
SOURCE: Dynatronics Corporation
View source version on accesswire.com:
https://www.accesswire.com/544737/Dynatronics-Schedules-Conference-Call-to-Report-Financial-Results-for-Third-Fiscal-Quarter-2019
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…